{"title":"利用DNA标记预测动脉粥样硬化的遗传易感性","authors":"P. Frossard, S. Vinogradov","doi":"10.1159/000416891","DOIUrl":null,"url":null,"abstract":"By seeking DNA markers, or restriction fragment length polymorphisms (RFLPs), associated with the presence of atherosclerosis in clinically relevant populations, investigators in the field of molecular genetics make use of the role played by various genetic components in the genesis of the disease to develop prognostic tests which identify those individuals who carry an underlying genetic predisposition to develop atherosclerotic cardiovascular disease","PeriodicalId":76182,"journal":{"name":"Monographs in human genetics","volume":"178 1","pages":"110-124"},"PeriodicalIF":0.0000,"publicationDate":"1989-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000416891","citationCount":"2","resultStr":"{\"title\":\"Using DNA markers to predict genetic susceptibility to atherosclerosis\",\"authors\":\"P. Frossard, S. Vinogradov\",\"doi\":\"10.1159/000416891\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"By seeking DNA markers, or restriction fragment length polymorphisms (RFLPs), associated with the presence of atherosclerosis in clinically relevant populations, investigators in the field of molecular genetics make use of the role played by various genetic components in the genesis of the disease to develop prognostic tests which identify those individuals who carry an underlying genetic predisposition to develop atherosclerotic cardiovascular disease\",\"PeriodicalId\":76182,\"journal\":{\"name\":\"Monographs in human genetics\",\"volume\":\"178 1\",\"pages\":\"110-124\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1989-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1159/000416891\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Monographs in human genetics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000416891\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Monographs in human genetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000416891","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Using DNA markers to predict genetic susceptibility to atherosclerosis
By seeking DNA markers, or restriction fragment length polymorphisms (RFLPs), associated with the presence of atherosclerosis in clinically relevant populations, investigators in the field of molecular genetics make use of the role played by various genetic components in the genesis of the disease to develop prognostic tests which identify those individuals who carry an underlying genetic predisposition to develop atherosclerotic cardiovascular disease
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
